SUSMED,Inc. (TYO:4263)

Japan flag Japan · Delayed Price · Currency is JPY
888.00
-27.00 (-2.95%)
At close: Nov 10, 2025
-2.95%
Market Cap14.93B
Revenue (ttm)475.00M
Net Income (ttm)-255.00M
Shares Out16.81M
EPS (ttm)-15.17
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume205,300
Average Volume149,830
Open906.00
Previous Close915.00
Day's Range870.00 - 906.00
52-Week Range413.00 - 1,012.00
Beta1.32
RSI52.55
Earnings DateNov 7, 2025

About SUSMED,Inc.

SUSMED,Inc. develops and sells therapeutic applications in Japan. It develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. The company also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, it offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan. [Read more]

Industry Medical - Healthcare Information Services
Sector Healthcare
Founded 2015
Employees 43
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4263
Full Company Profile

Financial Performance

In 2025, SUSMED,Inc.'s revenue was 462.00 million, an increase of 35.09% compared to the previous year's 342.00 million. Losses were -298.00 million, -16.53% less than in 2024.

Financial Statements

News

There is no news available yet.